EyeQue

EyeQue was founded under the premise that everyone should have access to eye care. EyeQue provides the tools for everyone to get glasses online by themselves.

EyeQue has over 100,000 users worldwide.
We have enrolled 20 optical stores onto our digital platform.

D2C - direct to consumers
B2B - optometry, ophthalmology, health and wellness, government, corporations, insurance, schools, optical stores, and many more.

In the US, 100M people, only a half of the people who need it, get an eye exam every year. But even that is more than a quarter million exams per day.
The main challenges are access and cost. Many people do not have access to an eye doctor or cannot afford one.
Other challenges include the hassle in getting an eye exam and the fact that most people do not consider it a high priority.

We developed a digital platform, EyeQue Connect, that allows anyone, from anywhere, at anytime to access eyecare.
EyeQue's screening devices bring a virtual environment to perform the most common vision screening tests – the wall chart, color blindness, common eye diseases like cataract, and central vision.
EyeQue is the only company that has the technology for a self-administered measurement of the numbers in your glasses prescription.

There is no other company that can perform a self-administered refraction measurement (numbers needed for glasses).
The main competitors are:
Digital Optometrics - B2B only, requires significant infrastructure and investment to start, aimed at the professional market only.
Visibly - visual acuity measurement only, cannot update prescription, cannot create new prescription.
6over6 - no solution is yet on the market.

EyeQue is the only company that has self-refraction technology. We have an ambitious roadmap and the people with the know-how to implement it.

SaaS - monthly subscription, per-use services (e.g. prescriptions, patient imaging records)
Device sales - direct to consumers, B2B, B2B2C.

SaaS and device sales.
Direct online sales and sales through distributors.
Sales through doctors.

EyeQue is looking for an investment to improve our technology and to achieve widespread adoption of our solutions.
We are looking to raise 5-10 million dollars to allow us to execute our plan of improving our technology and significantly expanding our sales operations.

We currently have a lot of the necessary components, but we are looking to improve the solutions and distribute them to the masses.

From a technology perspective, we would like to improve our digital platform to become an all-in-one solution for eye care.

This will include expanding the applications and use cases, integrating devices that already exist in the market, and adding artificial intelligence for both customer interaction and data management and analysis.

On the screening front, we would like to add tests to the existing devices as well as integrate additional test like field of view and imaging.
We would like to have a complete solution for performing these tests for both in office or at home.

Refraction measurement is already enabled with our current devices, but we would like to make them easier to use by making the tests faster and integrating AI into the test flow.

This will make it much easier to adopt and would potentially even improve the device accuracy.
In the office, we would also develop a binocular device that has been clinically proven to allow accurate measurements of young children.

EyeQue never lacks ideas. We have a very rich roadmap with no technological barriers.

EyeQue never lacks ideas. We have a very rich roadmap with no technological barriers.

Adoption challenges.

None.

5 CES awards 2017-2021
SPIE prism award finalist
Frost and Sullivan - Leader in ophthalmology award 2020

19 granted US and International patents
20 pending patent applications
50+ trademarks